With Testing Already Low, Mexico Lost 93,803 Covid Lab Results
(Bloomberg) -- Mexico has lost or discarded 93,803 results of Covid-19 tests throughout the pandemic, health officials said, reducing the nation's already low levels of testing for the virus.
The reasons behind the lost results vary. Some never made it to the lab from clinics and some weren't properly refrigerated or took too long to be processed, said Health Ministry epidemiology director Jose Luis Alomia at a Tuesday evening press conference.
Medical experts and international bodies like the United Nations have challenged Mexico's reduced testing, which has led the country to a 41% positivity rate, the second highest in the world according to Our World in Data. The Latin-American nation has foregone wide-scale exams, and instead the government runs them only on sick patients.
The lost results account for about 5% of total tests. As of Tuesday, Mexico had notified 1,935,334 people of their results, Alomia said.
Mexico has 738,163 confirmed cases, very close to Argentina's 736,609. Yet Mexico's death toll at 77,163 is almost five times that of the South American country, which stands at 16,519.
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.